UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

The lancet oncology, 2013-05, Vol.14 (6), p.472-480

2013

Volltextzugriff (PDF)

An Enhanced Recovery after Surgery Protocol in Children Who Undergo Nephrectomy for Wilms Tumor Safely Shortens Hospital Stay

Journal of pediatric surgery, 2022-10, Vol.57 (10), p.259-265

2022

Volltextzugriff (PDF)

Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)

Clinical cancer research, 2021-07, Vol.27 (13), p.3543-3548

2021

Volltextzugriff (PDF)

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

The oncologist (Dayton, Ohio), 2018-01, Vol.23 (1), p.52-61

2018

Volltextzugriff (PDF)

Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group

Journal of clinical oncology, 2017-11, Vol.35 (33), p.3781-3787

2017

Volltextzugriff (PDF)

Age-dependent reference intervals in children for the disialoganglioside, GD2, a circulating tumor biomarker for the childhood cancer, neuroblastoma

Clinical biochemistry, 2022-03, Vol.101, p.1-4

2022

Volltextzugriff (PDF)

Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers

Pediatric blood & cancer, 2024-09, Vol.71 (9), p.e31139

2024

Volltextzugriff (PDF)

Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy

Scientific reports, 2023-08, Vol.13 (1), p.12683-12683, Article 12683

2023

Volltextzugriff (PDF)

Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma

Clinical cancer research, 2013-08, Vol.19 (15), p.4239-4248

2013

Volltextzugriff (PDF)

Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium

Journal of clinical oncology, 2011-03, Vol.29 (7), p.839-844

2011

Volltextzugriff (PDF)

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Journal of clinical oncology, 2010-09, Vol.28 (25), p.3979-3986

2010

Volltextzugriff (PDF)

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

British journal of cancer, 2024-03, Vol.130 (5), p.788-797

2024

Volltextzugriff (PDF)

Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials

Cancer, 2024-11, Vol.130 (22), p.3785-3796

2024

Volltextzugriff (PDF)

Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task Force

Pediatric blood & cancer, 2017-11, Vol.64 (11), p.n/a

2017

Volltextzugriff (PDF)

A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report

Clinical cancer research, 2012-11, Vol.18 (21), p.6011-6022

2012

Volltextzugriff (PDF)

15-0600-Dr. Fox’s response to letter to the editor

Cancer chemotherapy and pharmacology, 2016-11, Vol.78 (5), p.1099-1100

2016

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors

Cancer chemotherapy and pharmacology, 2015-12, Vol.76 (6), p.1273-1283

2015

Volltextzugriff (PDF)

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

Clinical cancer research, 2011-02, Vol.17 (3), p.569-580

2011

Volltextzugriff (PDF)

A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5174-5181

2010

Volltextzugriff (PDF)

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2014-05, Vol.16 (5), p.707-718

2014

Volltextzugriff (PDF)

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report

Journal of the American Heart Association, 2023-10, Vol.12 (19), p.e029954-e029954

2023

Volltextzugriff (PDF)

Diagnosis of Beckwith–Wiedemann syndrome in children presenting with Wilms tumor

Pediatric blood & cancer, 2018-10, Vol.65 (10), p.e27296-n/a

2018

Volltextzugriff (PDF)

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium

Cancer chemotherapy and pharmacology, 2017-01, Vol.79 (1), p.181-187

2017

Volltextzugriff (PDF)

Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib

Clinical cancer research, 2018-02, Vol.24 (4), p.753-765

2018

Volltextzugriff (PDF)

Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates

Cancer chemotherapy and pharmacology, 2010-04, Vol.65 (5), p.817-824

2010

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(323)
Mit Volltextzugriff
(296)

Publikationsform

Sprache

Englisch
(332)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

An Enhanced Recovery after Surgery Protocol in Children Who Undergo Nephrectomy for Wilms Tumor Safely Shortens Hospital Stay

Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group

Age-dependent reference intervals in children for the disialoganglioside, GD2, a circulating tumor biomarker for the childhood cancer, neuroblastoma

Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers

Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy

Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma

Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials

Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task Force

A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report

15-0600-Dr. Fox’s response to letter to the editor

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report

Diagnosis of Beckwith–Wiedemann syndrome in children presenting with Wilms tumor

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium

Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib

Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates

Suchergebnisse filtern